An Open Secret

Premium

One of the most widely known instances of scientific ghostwriting involves Wyeth, the medical-writing company DesignWrite, and the hormone replacement drugs Premarin and Prempro. According to documents that PLoS and the New York Times sued to make available to the public, and which are now housed on a website at the University of California, San Francisco, DesignWrite and Wyeth developed research and review articles that portrayed hormone replacement therapies in a positive light.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.